Clinical Trials Directory

Trials / Completed

CompletedNCT02761837

The Breathe Well Program for Adults With Asthma

The Breathe Well Program to Improve Asthma Outcomes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14,978 (actual)
Sponsor
National Jewish Health · Academic / Other
Sex
All
Age
19 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

Detailed description

Breathe Well uses the Kaiser Permanente Electronic Health Record (EHR) to identify asthma exacerbation risk factors. For patients with a history of frequent exacerbations or B-agonist overuse, the EHR notifies a nurse who uses an EHR-generated tailored clinical report and patient directed decision support tool to engage and empower patients to develop an action plan in collaboration with providers. EHR-templated notes and order sets facilitate care plan execution. Poor controller medication adherence or unaddressed smoking results in the patient being automatically enrolled in an IBCT medication refill or smoking cessation program. Breathe Well uses multiple EHR functions and a patient and provider team to address barriers to evidence-based asthma care for providers.The study will be conducted in 26 primary care clinics of Kaiser Permanente Colorado (KPCO) using a pragmatic clinical trial design. Up to 15,000 high-risk asthma patients will be assigned to Breathe Well or guideline-based usual care based on their clinic.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIVR call/textFor patients under filling their inhaled corticosteroid or overusing B-agonist, the patient is contacted via IVR call or text
BEHAVIORALEmailPatients under filling their inhaled corticosteroid or overusing B-agonist, the the patient is contacted via email

Timeline

Start date
2016-10-01
Primary completion
2023-06-01
Completion
2023-06-01
First posted
2016-05-04
Last updated
2023-11-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02761837. Inclusion in this directory is not an endorsement.